<DOC>
	<DOCNO>NCT01095185</DOCNO>
	<brief_summary>This prospective , double blind control trial patient esophagic variceal bleeding treat standard therapy ( endoscopic variceal ligation ( EVL ) + B-blockers ) , randomize receive statin placebo . They follow 12 month determinate whether statin effective prevention variceal bleed recurrence evaluate patient survival . Randomization stratify accord degree hepatic insufficiency , assess Child-Pugh classification ( A , B C ) .</brief_summary>
	<brief_title>Efficacy Statin Association With Standard Treatment Prevention Recurrent Hemorrhage Patient With Cirrhosis Variceal Bleeding</brief_title>
	<detailed_description>A mayor cause cirrhosis-related morbility mortality development variceal hemorrhage , direct consequence portal hypertension . In addition , survivor episode active bleed 70 % risk recurrent hemorrhage within two year bleed episode high risk situate first six week hemorrhage episode . The recommended treatment AASLD guideline combination non selective Betablockers endoscopic treatment EVL , high recurrence ( 30 % 2 year ) . The hypothesis study statins candidate improve portal hypertension treatment patient cirrhosis , improve vascular function well prevent venous thrombotic event . Patients liver cirrhosis variceal bleed standard treatment stratify randomize undergo either statin ( 20 mg 15 day , 40 mg/day ) placebo . They follow 12 month .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients 18 80 year old . Clinical criterion and/or analytical , ultrasound and/or liver biopsy consistent diagnosis liver cirrhosis . Hematemesis melenas within 7 day prior study inclusion . Variceal bleeding . Endoscopic diagnosis : Active variceal bleeding . Clot platelet cluster , Esophageal varix associate red blood esophagogastric lumen absence source bleed . Patients standard treatment prevention recurrence variceal bleeding ( EVL+B Blockers , Propanolol ) . Women childbearing age urine pregnancy test negative 7 day commencement treatment postmenopausal woman must amenorrhea least 12 month consider fertile . Potential childbearing woman men must commit use adequate contraception prior join study . Written inform consent participate study . Pregnancy lactation Presence multiple hepatocellular carcinoma diameter &gt; 5 cm . Renal failure ( Creatinine &gt; 2 mg/dl ) Advanced liver disfunction ( Child Pugh &gt; 13 point ) Contraindication statin . Patients HIV treat antiretroviral therapy . Pretreatment portosystemic shunt ( surgical percutaneous ) . Bleeding due gastric varix . Patients total portal vein thrombosis portal cavernomatosis . Patients previously treat endoscopic variceal ligation B Blockers ( index episode ) . Patients previously treat statin ( one month study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>